Appeal No. 2001-2138
Application No. 08/403,276
where R represents hydrogen, a lower alkyl radical,
or an acyl radical of a lower organic acid. (RousselSUclaf I at 1, left column; Bertin at col.
1, ll.15–30.)
13. These compounds may be named 3-OR-20-(N,N-
1,2,5(10)
dimethylaminoethylamino)-19-nor-) -pregnatrienes. (RUSI at 1, right column, ll.5–6;
Bertin at col. 2, ll.69–70, and Table I at col. 3 (chemical reaction scheme).)
14. The compounds are disclosed to have antilipemic and
hypocholesterolemiantic activities, and to lack any estrogenic activity. (RUSI at 1, left
column, second paragraph; Bertin at col. 2, ll.40–43.)
15. The disclosed synthesis of the inventive compounds begins with
1,3,5(10)
compounds of formula II, such as 3-OR 20-oxo 19-nor ) -pregnatriene. (RUS1 at 1,
- 7 -
Page: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next
Last modified: November 3, 2007